Expand ANAB Menu
ANAB MENU

ANAB Latest Press Releases

-- November 25, 2025 --

Anaptys Announces Participation in December Investor Conferences Globe Newswire 4:15 PM

-- November 21, 2025 --

Anaptys Announces $100 Million Stock Repurchase Plan Globe Newswire 4:00 AM
Anaptys Initiates Litigation Against Tesaro, a GSK Subsidiary Globe Newswire 3:50 AM

-- November 10, 2025 --

Anaptys Announces Phase 2 Trial of Rosnilimab Did Not Meet Primary or Secondary Endpoints at Week 12 in Moderate-to-Severe Ulcerative Colitis Globe Newswire 9:00 AM

-- November 4, 2025 --

Anaptys Announces Third Quarter 2025 Financial Results and Provides Business Update Globe Newswire 4:15 PM
Anaptys Announces Participation in November Investor Conferences Globe Newswire 4:15 PM

-- October 29, 2025 --

Anaptys Announces New Positive Phase 2b Trial Results for Rosnilimab in Rheumatoid Arthritis at ACR Late-Breaking Oral Presentation Globe Newswire 9:15 AM

-- October 13, 2025 --

Anaptys Announces Late-Breaking Oral Presentation of Complete Phase 2b Data for Rosnilimab in Rheumatoid Arthritis at Upcoming ACR Convergence 2025 Globe Newswire 9:15 AM

-- September 29, 2025 --

Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026 Globe Newswire 4:05 PM
Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14 Globe Newswire 4:05 PM

-- August 27, 2025 --

Anaptys Announces Participation in September Investor Conferences Globe Newswire 4:15 PM

-- August 6, 2025 --

Anaptys Announces Second Quarter 2025 Financial Results and Provides Business Update Globe Newswire 4:15 PM
Market Data Delayed 15 Minutes